Ganglioside-exposed dendritic cells inhibit T-cell effector function by promoting regulatory cell activity

Immunology

Volumn 132, Issue 1, 2011, Pages 134-143

  Jales, Alessandra ^a   Falahati, Rustom ^a   Mari, Elisabeth ^a   Stemmy, Erik J ^a   Shen, Weiping ^b   Southammakosane, Cathy ^a   Herzog, Dallen ^a   Ladisch, Stephan ^b,c   Leitenberg, David ^a,b,c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CHILDREN S RESEARCH INSTITUTE   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Dendritic cells; Gangliosides; T helper effector cells; Tolerance suppression

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; GANGLIOSIDE GD 1A; GANGLIOSIDE GM1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL POPULATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMUR; HELPER CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TIBIA;

ANIMALS; DENDRITIC CELLS; GANGLIOSIDES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 78650024240     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2010.03348.x     Document Type: Article

References (31)

1. Ladisch S, Gillard B, Wong C, Ulsh L. Shedding and immunoregulatory activity of YAC-1 lymphoma cell gangliosides. Cancer Res 1983; 43:3808-13.
2. Bernhard H, Meyer Zum Buschenfelde KH, Dippold WG. Ganglioside GD3 shedding by human malignant melanoma cells. Int J Cancer 1989; 44:155-60.
3. Portoukalian J, David MJ, Gain P, Richard M. Shedding of GD2 ganglioside in patients with retinoblastoma. Int J Cancer 1993; 53:948-51.
4. Ladisch S, Wu ZL. Detection of a tumour-associated ganglioside in plasma of patients with neuroblastoma. Lancet 1985; 1:136-8.
5. Valentino L, Moss T, Olson E, Wang HJ, Elashoff R, Ladisch S. Shed tumour gangliosides and progression of human neuroblastoma. Blood 1990; 75:1564-7.
6. Liu Y, Mccarthy J, Ladisch S. Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling. Cancer Res 2006; 66:10408-14.
7. Li R, Liu Y, Ladisch S. Enhancement of epidermal growth factor signaling and activation of SRC kinase by gangliosides. J Biol Chem 2001; 276:42782-92.
8. Ladisch S, Ulsh L, Gillard B, Wong C. Modulation of the immune response by gangliosides: inhibition of adherent monocyte accessory function in vivo. J Clin Invest 1984; 74:2074-81.
9. Uzzo RG, Rayman P, Kolenko V et al. Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. J Clin Invest 1999; 104:769-76.
10. Shurin GV, Shurin MR, Bykovskaia S, Shogan J, Lotze MT, Barksdale EM Jr. Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function. Cancer Res 2001; 61:363-9.
11. Robb RJ. The suppressive effect of gangliosides upon IL-2-dependent proliferation as a function of inhibition of IL-2 receptor association. J Immunol 1986; 136:971-6.
12. Chu JW, Sharom FJ. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors. Immunology 1993; 79:10-7.
13. Biswas K, Richmond A, Rayman P et al. GM2 expression in renal cell carcinoma: potential role in tumor-induced T cell dysfunction. Cancer Res 2006; 66:6816-25.
14. Das T, Sa G, Hilston C et al. GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce T-cell apoptosis. Cancer Res 2008; 68:2014-23.
15. Crespo FA, Sun X, Cripps JG, Fernandez-Botran R. The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses. J Leukoc Biol 2006; 79:586-95.
16. + regulatory T cells function. Int Immunol 2008; 20:591-600.
17. Shen W, Ladisch S. Ganglioside GD1a impedes lipopolysaccharide-induced maturation of human dendritic cells. Cell Immunol 2002; 220:125-33.
18. Mond JJ, Witherspoon K, Yu RK, Perera PY, Vogel SN. Inhibition of LPS-mediated cell activation in vitro and in vivo by gangliosides. Circ Shock 1994; 44:57-62.
19. Mckallip R, Li R, Ladisch S. Tumor gangliosides inhibit the tumor-specific immune response. J Immunol 1999; 163:3718-26.
20. Reiner SL. Development in motion: helper T cells at work. Cell 2007; 129:33-6.
21. + T cells in transgenic mice express a class II MHC restricted antigen receptor. Nature 1989; 341:746-9.
22. Shen W, Falahati R, Stark R, Leitenberg D, Ladisch S. Modulation of CD4 Th cell differentiation by ganglioside GD1a in vitro. J Immunol 2005; 175:4927-34.
23. Leitenberg D, Bottomly K. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol 1999; 11:283-92.
24. Leitenberg D, Boutin Y, Constant S, Bottomly K. CD4 regulation of T cell receptor signaling and T cell differentiation following stimulation with peptides of different affinities for the T cell receptor. J Immunol 1998; 161:1194-203.
25. Shen W, Stone K, Jales A, Leitenberg D, Ladisch S. Inhibition of TLR activation and up-regulation of IL-R-associated kinase-M expression by exogenous gangliosides. J Immunol 2008; 180:4425-32.
26. Rabinovitch GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25:267-96.
27. Belkaid Y, Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 2008; 29:362-71.
28. + T cells after pediatric hematopoietic stem cell transplantation. Haematologica 2006; 91:566-9.
29. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110:191-202.
30. Xie Q, Gan L, Wang J, Wilson I, Li L. Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth. Mol Immunol 2007; 44:3453-61.
31. Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ. Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 2007; 27:635-46.